Sun Pharma slips as Dadra facility receives USFDA warning letter

Sun Pharmaceuticals Industries fell 1.70% to Rs 1,478.55 after the company announced that it has received a warning letter from United States Food & Drug Administration (USFDA) for its Dadra facility.